N/A
N=101
Role of Apathy in the Effectiveness of Weight Loss Interventions
Obesity · Apathy
Bottom Line
View on ClinicalTrials.gov: NCT00548652 ↗Enrolled (actual)
101
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Apathy Evaluation Scale — -7.69; -6.4; -6.15 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MOVE (Behavioral); medical crisis councelling (Behavioral); methyphenidate (Drug)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- VA Nebraska Western Iowa Health Care System
- Primary completion
- May 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Apathy Evaluation Scale |
-7.69; -6.4; -6.15 | — |
| SECONDARY Change in Weight |
-0.6; -0.61; -4.61 | — |
Summary
The purpose of this study is to determine whether treating apathy with methylphenidate or medical Crisis counselling will increase adherence to weight loss programs thereby increasing their effectiveness
Eligibility Criteria
Inclusion Criteria
- BMI >30
- Apathy score >40
Exclusion Criteria
- History of cancer, except basal cell
- Cardiovascular event in last 6 months
- Renal failure
Data sourced from ClinicalTrials.gov (NCT00548652). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.